China Universal Asset Management Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Buy |
|
|||||
|
2025
Q1 | $406K | Sell |
|
|||||
|
2024
Q4 | $429K | Buy |
|
|||||
|
2024
Q3 | $352K | Buy |
|
|||||
|
2024
Q2 | $178K | Sell |
|
|||||
|
2024
Q1 | $251K | Buy |
|
|||||
|
2023
Q4 | $144K | Buy |
|
|||||
|
2023
Q3 | $26.4K | Buy |
|
|||||
|
2023
Q2 | $16.3K | Sell |
|
|||||
|
2023
Q1 | $17K | Buy |
|
|||||
|
2022
Q4 | $11.4K | Sell |
|
|||||
|
2022
Q3 | $14K | Buy |
|